Anaconda Biomed News

Latest Anaconda Biomed news, funding rounds and robotics & AI coverage. $56M raised. 1 article tracked by The Robotics Media.

About Anaconda Biomed

Anaconda Biomed is a Spanish medical-device company founded in 2014 that develops neurovascular tools for acute ischemic stroke, headquartered in Barcelona with US operations in Marin County, California. Its flagship product, the ANA Funnel Catheter platform (ANA5, ANA6, ANA8), is designed to improve first-pass clot removal during mechanical thrombectomy procedures.

ANA5 is CE-marked in Europe and investigational in the US, where it is being studied in the ATHENA pivotal IDE trial. CEO Trent Reutiman leads the company.

Key facts

• Headquarters: Barcelona, Catalonia, Spain
• Country: Spain
• Founded: 2014
• Sectors: Surgical Robotics, Digital Health
• Website: https://anaconda.bio

Products by Anaconda Biomed

• ANA Funnel Catheter (Robot, 2020) — A funnel-tipped catheter platform designed to trap and retrieve blood clots in one pass during mechanical thrombectomy. The ANA5 variant is CE-marked in Europe...
• Conda Stent Retriever (Robot, 2024) — A companion stent retriever designed to work with the ANA Funnel Catheter to maximize first-pass complete revascularization in acute ischemic stroke procedures.

Funding rounds

• Series E — $56M — 2026 — led by Omega Funds

Latest Anaconda Biomed news

• Anaconda Biomed Bags $56M To Finish US Stroke Catheter Pivotal Trial — Omega Funds led a $56M raise into Barcelona's Anaconda Biomed to finish the 327-patient ATHENA trial for its ANA Funnel Catheter stroke thrombectomy p...